Recruitment for Medical Representative at Alembic Pharmaceuticals Ltd

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Post : Medical Representative

Job for Junior Research Fellow at NII

The National Institute of Immunology (NII) is committed to advanced research addressing the basic mechanisms involved in body's defence to identify modalities for manipulation of the immune system to provide protection against diseases and understand mechanisms that can be used to target disease processes for intervention. The institute’s research thrust areas under immunology and related disciplines cluster in four main themes, namely, infection and immunity, molecular design, gene regulation and reproduction and development, where cutting edge research in modern biology is being carried out.

Post : Junior Research Fellow (Project)

Career for Pharmacy graduates as Marketing Manager at AstraZeneca

AstraZeneca is an exciting global, innovation-driven biopharmaceutical company. We’re inspired by what science can do. Driven by the desire to meet unmet patient needs in our core therapeutic areas. Bold in our thinking. Proactive in pursuing discoveries beyond imagination. At sites across the world, we bring teams together in a spirit of collaboration to turn great ideas into life-changing medicines – strengthening our product portfolio and harnessing the potential of a pipeline across all stages of the drug development process.

Post : Marketing Manager- Frontier Markets

Vacancy for Research Assistant, Technical Expert at TUMAAS

TUMAAS is the Foundation for TB, Malnutrition and AIDs in Kandivali,  Mumbai. TUMAAS has been working in healthcare sector, awareness programs for great societal impact. Recently, TUMAAS has been awarded with Aarohan Social Innovation Award from Infosys Foundation.  TUMAAS provides suitable platform for conducting research on tuberculosis, child malnutrition and AIDS.  Presently, TUMAAS has been working in collaboration with different national and international organizations for different R & D activities on COVID-19, TB and Malnutrition.

Post : Research Assistant / Technical Expert

Opportunity for Pharmacy graduates at Covance

Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.

Post : Asst II PSS

Administrative Assistant require at TUMAAS

TUMAAS is the Foundation for TB, Malnutrition and AIDs in Kandivali,  Mumbai. TUMAAS has been working in healthcare sector, awareness programs for great societal impact. Recently, TUMAAS has been awarded with Aarohan Social Innovation Award from Infosys Foundation.  TUMAAS provides suitable platform for conducting research on tuberculosis, child malnutrition and AIDS.  Presently, TUMAAS has been working in collaboration with different national and international organizations for different R & D activities on COVID-19, TB and Malnutrition.

Post : Administrative Assistant

Sun Pharmaceutical Industries Ltd and includes its subsidiaries and/or associate companies) has announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial with Nafamostat Mesilate in Covid-19 patients. Nafamostat is approved in Japan for improvement of acute symptoms of pancreatitis and treatment of Disseminated Intravascular Coagulation (DIC).

The Centre for Cellular and Molecular Biology (CCMB) has established stable cultures of coronavirus (SARS-CoV-2) from patients’ samples. Virologists at CCMB have isolated infectious viruses from several isolates. The ability to culture the virus in lab enables CCMB to work towards vaccine development and testing of potential drugs to fight COVID-19.

Roche announced European Medicines Agency (EMA) approval of a new, shorter two-hour OCREVUS® (ocrelizumab) infusion time, dosed twice yearly, for relapsing or primary progressive multiple sclerosis (MS). The approval is based on a positive opinion from the EMA’s Committee for Medicinal Products for Human Use (CHMP).

Sun Pharma Advanced Research Company Ltd and Sun Pharmaceutical Industries Ltd. announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders. SCD-044 is entering phase 2 clinical trials.